MSD-CYP11B2 |
Inhibitor of CYP11B2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CYP11B2 |
|
Inhibitor
25 - 100 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Human CYP11B1: IC50 = 142 nM (Assay using V79 cell lines); 61x more selective for CYP11B2 compared t ...
Potency Cellular
In Vitro
CYP11B2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acsmedchemlett.5b00054
In Vivo Validations
Rat
Dose: 1 mg/kg
Route of delivery:
Intravenous
Systemic clearance:
10 mL/min/kg
Area Under the Curve::
4.32 μM·h·kg/mg
Fb :
87 %
Bioavailability:
76 %
DOI Reference: 10.1021/acsmedchemlett.5b00054
Monkey (Rheus)
Dose: 0.5 mg/Kg
Route of delivery:
Intravenous
Systemic clearance:
5 mL/min/kg
Area Under the Curve::
1.53 μM·h·kg/mg
Fb :
85 %
Bioavailability:
15 %
DOI Reference: 10.1021/acsmedchemlett.5b00054
Negative Control Compounds
Chemical Information
| Molecular Formula | C18H18FN3O |
| SMILEs | CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 |
| InChI | InChI=1S/C18H18FN3O/c1-18(2,23)12-7-11(9-20-10-12)17-21-15-6-3-13(19)8-16(15)22(17)14-4-5-14/h3,6-10,14,23H,4-5H2,1-2H3 |
| Molecular weight | 311.14 Da |
| AlogP | 3.7997000000000023 |
| HBond acceptors | 4 |
| HBond donors | 1 |
| Atoms | 41 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.